BeStock  
Stocks › Medical Devices › LMRI

Lumexa Imaging LMRI

US equityMarket cap rank #2940Medical Devices
$14.26 +$0.20 (+1.42%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $14.26 0.00%
Open$13.87
Prev close$14.06
Day range$13.87 – $14.47
Volume442.4K
Market cap$1.37B
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: Q3, ended Sep 2026

Revenue$271.97M+5.0% YoY
Operating profit$6.05M-53.4% YoY
Net profit$7.18M+305.0% YoY
Diluted EPS$0.07+289.1% YoY
Free cash flow$20.60M+1,266.7% YoY
Operating cash flow$34.81M

Revenue, last 8 quarters

$248.0MDec '24$245.0MMar '25$251.4MJun '25$258.9MSep '25$267.7MDec '25$252.5MMar '26$264.2MJun '26$272.0MSep '26

Net profit, last 8 quarters

$-25.1MDec '24$-7.7MMar '25$-7.2MJun '25$-3.5MSep '25$-28.7MDec '25$1.7MMar '26$2.7MJun '26$7.2MSep '26

Diluted EPS by quarter

-0.26Dec '24-0.08Mar '25-0.08Jun '25-0.04Sep '25-0.38Dec '250.02Mar '260.03Jun '260.07Sep '26

Free cash flow by quarter

$19.4MDec '24$-15.0MMar '25$-2.5MJun '25$-1.8MSep '25$12.9MDec '25$-2.4MMar '26$22.5MJun '26$20.6MSep '26

Annual revenue

$935.9MFY23$948.9MFY24$1.0BFY25

Profitability & balance sheet

Gross margin15.4%
Operating margin0.7%
Net margin-1.6%
Return on equity-4.3%
Return on assets-1.0%
Return on invested capital1.9%
Current ratio1.52
Liabilities / assets65.4%
Cash & investments$90.01M
Total debt$949.55M
Net cash (debt)-$859.54M
Free cash flow / sales5.1%

Where the revenue comes from

Quarter 2026/Q2

By business line

  • Outpatient$196.21M 73.1%
  • Professional$72.25M 26.9%

Income statement

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Revenue as Reported $271.97M $264.16M $252.54M $1.02B $267.73M
Total Operating Revenue $271.97M $264.16M $252.54M $1.02B $267.73M
Cost of Revenue $225.57M $225.29M $217.76M $865.52M $225.62M
Gross Profit $46.40M $38.88M $34.78M $157.57M $42.12M
Operating Expense $40.36M $34.48M $30.26M $130.83M $49.59M
Selling and Admin Expenses $30.03M $24.40M $20.34M $90.45M $37.19M
-General & Admin Expense $30.03M $24.40M $20.34M $90.45M $37.19M
Depreciation & Amortization & Depletion $10.33M $10.08M $9.92M $40.38M $12.40M
-Depreciation & Amortization $10.33M $10.08M $9.92M $40.38M $12.40M
Operating Profit $6.05M $4.40M $4.53M $26.73M -$7.47M
Net Non-Operating Interest Income (Expense) -$15.67M -$16.22M -$16.33M -$118.54M -$28.02M
Non-Operating Interest Expense $15.67M $16.22M $16.33M $118.54M $28.02M
Other Income (Expense) $21.41M $17.59M $14.89M $59.59M $10.23M
Earnings from Equity Interest $22.85M $18.62M $15.02M $72.14M $22.30M
Special Income (Charges) -$779,000.00 -$1.03M -$137,000.00 -$14.42M -$13.94M
-Gain on Sale of Property/Plant/Equipment -$779,000.00 $24,000.00 -$137,000.00 -$968,000.00 -$491,000.00
Other Non-Operating Income (Expenses) -$654,000.00 – – $1.87M –
Pretax Profit $11.79M $5.77M $3.08M -$32.22M -$25.26M
Tax $4.61M $3.02M $1.36M $14.89M $3.43M
Net Profit $7.18M $2.75M $1.72M -$47.10M -$28.69M
Profit from Continuing Operations $7.18M $2.75M $1.72M -$47.10M -$28.69M
Net Income to Parent Company $7.18M $2.75M $1.72M -$47.10M -$28.69M
Net Income to Common Stockholders $7.18M $2.75M $1.72M -$47.10M -$28.69M
Basic EPS $0.07 $0.03 $0.02 -$0.66 -$0.38
Diluted EPS $0.07 $0.03 $0.02 -$0.66 -$0.38
-Less:Other Special Charges – $1.05M – $13.45M –
-Less:Impairment of Capital Assets – – – $0.00 –

Balance sheet

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Assets $1.83B $1.81B $1.76B $1.76B $1.76B
Total Current Assets $278.31M $256.42M $221.89M $227.26M $227.26M
Cash and Cash Equivalents & Short-Term Investments $90.01M $69.71M $51.23M $58.83M $58.83M
-Cash and Cash Equivalents $90.01M $69.71M $51.23M $58.83M $58.83M
Receivables $173.51M $172.21M $154.13M $150.85M $150.85M
-Accounts Receivable $140.34M $140.66M $134.08M $131.84M $131.84M
-Other Receivables $33.17M $31.55M $20.05M $15.52M $15.52M
Prepaid Assets $14.79M $14.50M $16.53M $17.58M $17.58M
Total Non-Current Assets $1.55B $1.55B $1.54B $1.54B $1.54B
Net PPE $233.68M $233.10M $226.30M $221.26M $221.26M
-Gross PPE $233.68M $233.10M $226.30M $500.82M $500.82M
Investments and Advances $428.02M $423.33M $420.52M $423.19M $423.19M
-Long Term Equity Investment $428.02M $423.33M $420.52M $423.19M $423.19M
Goodwill and Other Intangible Assets $846.14M $847.28M $847.80M $848.89M $848.89M
-Goodwill $807.55M $807.55M $807.55M $807.55M $807.55M
-Other Intangible Assets $38.58M $39.72M $40.25M $41.34M $41.34M
Other Non-Current Assets $46.99M $48.65M $46.85M $43.95M $43.95M
Total Liabilities $1.20B $1.19B $1.16B $1.18B $1.18B
Total Current Liabilities $183.46M $178.36M $157.93M $179.19M $179.19M
Payables $27.60M $33.61M $41.55M $49.19M $49.19M
-Accounts Payable $20.38M $27.06M $37.17M $44.86M $44.86M
-Total Tax Payable $5.62M $4.23M $535,000.00 $421,000.00 $421,000.00
-Other Payable $1.60M $2.32M $3.85M $3.91M $3.91M
Current Accrued Expenses $52.21M $52.69M $44.24M $41.87M $41.87M
Short-Term Debt and Capital Lease Obligation $45.15M $42.13M $40.59M $38.78M $38.78M
-Current Debt $17.87M $15.60M $15.13M $14.71M $14.71M
-Current Capital Lease Obligation $27.28M $26.53M $25.46M $24.07M $24.07M
Total Non-Current Liabilities $1.02B $1.02B $1.01B $999.24M $999.24M
Long Term Debt and Capital Lease Obligation $931.68M $933.23M $926.86M $923.73M $923.73M
-Long Term Debt $821.52M $819.75M $816.97M $819.03M $819.03M
-Long Term Capital Lease Obligation $110.16M $113.47M $109.89M $104.70M $104.70M
Non-Current Deferred Liabilities $47.04M $43.59M $41.50M $40.77M $40.77M
Other Non-Current Liabilities $36.87M $38.54M $37.44M $34.74M $34.74M
Total Equity $634.08M $615.06M $599.62M $586.12M $586.12M
Stockholders' Equity $634.08M $615.06M $599.62M $586.12M $586.12M
Capital Stock $96,000.00 $96,000.00 $96,000.00 $96,000.00 $96,000.00
-Common Stock $96,000.00 $96,000.00 $96,000.00 $96,000.00 $96,000.00
Additional Paid-In Capital $1.25B $1.24B $1.23B $1.22B $1.22B
Retained Earnings -$619.42M -$626.60M -$629.34M -$631.06M -$631.06M
-Taxes Receivable – – – $3.50M $3.50M
-Accumulated Depreciation – – – -$279.55M -$279.55M

Cash flow

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Operating Cash Flow $34.81M $32.80M $2.93M $17.07M $17.10M
Net cash flow from continuing operations $34.81M $32.80M $2.93M $17.07M $17.10M
Net Income from Continuing Operations $7.18M $2.75M $1.72M -$47.10M -$28.69M
Gain/Loss from Continuing Operations -$3.91M $576,000.00 $2.81M -$2.72M $5.42M
Depreciation & Depletion & Amortization $14.25M $14.08M $13.88M $55.39M $16.24M
Deferred Tax $3.45M $2.09M $726,000.00 $8.08M $4.57M
Other Non-Cash Items $801,000.00 $1.28M $384,000.00 $6.18M $1.57M
Change in Working Capital $432,000.00 -$711,000.00 -$28.86M -$44.35M -$581,000.00
-Change in Receivables -$1.30M -$18.09M -$3.28M -$14.01M -$1.50M
-Change in Prepaid Assets -$940,000.00 $1.46M $1.57M -$6.28M $92,000.00
-Change in Payables and Accrued Expense $5.76M $20.92M -$21.44M -$3.52M $2.37M
-Change in Other Current Assets $1.40M -$2.03M -$4.35M -$13.30M $3.80M
-Change in Other Current Liabilities -$4.49M -$2.99M -$1.37M -$7.24M -$5.34M
Net cash flow from investing -$14.05M -$13.64M -$5.27M -$20.96M -$2.40M
Net Cash Flow from Continuing Investing Activities -$14.05M -$13.64M -$5.27M -$20.96M -$2.40M
Net PPE Purchase and Sale -$14.05M -$9.67M -$5.27M -$20.83M -$2.40M
Net Intangibles Purchase and Sale $0.00 – – – –
Net Business Purchase and Sale $0.00 – – -$123,000.00 $0.00
Financing Cash Flow -$454,000.00 -$685,000.00 -$5.26M $36.58M $43.93M
Net Cash Flow from Continuing Financing Activities -$454,000.00 -$685,000.00 -$5.26M $36.58M $43.93M
Net Issuance Payments Of Debt -$786,000.00 -$199,000.00 -$5.26M -$381.92M -$373.74M
Net Common Stock Issuance $332,000.00 -$332,000.00 $0.00 $435.59M $434.75M
Net Other Financing Charges $0.00 – – -$17.08M –
Ending Cash Balance $90.01M $69.71M $51.23M $58.83M $58.83M
Net Change in Cash $20.31M $18.48M -$7.60M $32.70M $58.64M
Beginning Cash Balance $69.71M $51.23M $58.83M $26.13M $191,000.00
Free Cash Flow $20.60M $22.53M -$2.38M -$6.40M $12.85M

Discussion

No comments yet — be the first to weigh in on LMRI.

Sign in to join the discussion.

Scroll to Top